Dr. Sol Barer
Celgene Corporation’s commitment to making top quality innovative and life-changing medications for patients facing serous and debilitating diseases deserves widespread recognition and applause. Dr. Barer has been Chief Executive Officer of Celgene since 2006 and Chairman since 2007. He founded the biotechnology group at Celanese that was subsequently spun out to form Celgene. Celgene is currently one of the world’s largest biotechnology companies with a market capitalization of over $20 Billion.